CIPLA FDA Approval ANDA 204766

ANDA 204766

CIPLA

FDA Drug Application

Application #204766

Documents

Letter2017-06-06

Application Sponsors

ANDA 204766CIPLA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL600MG0EFAVIRENZEFAVIRENZ

FDA Submissions

UNKNOWN; ORIG1AP2018-06-15

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204766
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"EFAVIRENZ","activeIngredients":"EFAVIRENZ","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/15\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/204766Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-06-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.